Breaking News

Gilead Sciences Inc (GILD)

Symbol	Exchange	Currency
GILD	NASDAQ	USD	Real-time
0QYQ	London	USD	Real-time
GILD	Mexico	MXN	Delayed
GGILD	Milan	EUR	Real-time
GILD	Xetra	EUR	Delayed
GILD	Frankfurt	EUR	Delayed
GILD	TradeGate	EUR	Delayed
GILDm	Buenos Aires	ARS	Delayed
GILD34	B3	BRL	Delayed
GILD	Vienna	EUR	Real-time
GILD	Lima	USD	Delayed

Add to/Remove from a Portfolio Add to Watchlist

94.070 0.000 0.00%

17/07 - Real-time Data. Currency in EUR

Volume: 0
Bid/Ask: 93.050 / 93.870
Day's Range: 93.180 - 94.070

Type: Equity

Market: Austria

ISIN: US3755581036

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
Forum

Gilead Company Profile

Read the Gilead company profile to learn more about the business and the management team. View Gilead Sciences Inc facts about how many employees Gilead has, GILD company products and services, and contact information.

IndustryPharmaceuticals

SectorHealthcare

Employees

17600

Equity Type

DRC

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Contact Information

Address 333 Lakeside Drive
Foster City, 94404
United States

Phone 650 574 3000

Fax 650 578 9264

Web www.gilead.com

Top Executives

Name	Age	Since	Title
Grace E. Colon	56	2023	Chairman of the Board
Paul E. Klotman	-	-	Member of the Scientific Advisory Board
Paul Berg	98	1998	Member of Scientific Advisory Board
Eric J. Topol	71	-	Member of Scientific Advisory Board
John W. Mellors	87	-	Member of the Scientific Advisory Board
Robert A. Harrington	64	-	Member of the Scientific Advisory Board
Eugene R. Schiff	-	-	Member of the Scientific Advisory Board
Joel R. Huff	-	-	Chairperson of Scientific Advisory Board
Malcolm MacCoss	77	-	Member of Scientific Advisory Board
Nezam H. Afdhal	68	-	Member of Scientific Advisory Board
Daniel P. O'Day	60	2019	Chairman & CEO
Harish M. Manwani	72	2018	Independent Director
Jeffrey A. Bluestone	72	2020	Independent Director
Kelly A. Kramer	57	2016	Independent Director
Sandra J. Horning	76	2020	Independent Director
Javier J. Rodriguez	54	2020	Independent Director
Anthony Welters	70	2020	Lead Independent Director
Robert T. Schooley	-	-	Member of the Scientific Advisory Board
Francis V. Chisari	-	-	Member of the Scientific Advisory Board
Brian J. Druker	69	-	Member of the Scientific Advisory Board
Kenneth C. Anderson	74	-	Member of the Scientific Advisory Board
Ted W. Love	66	2024	Independent Director
Jacqueline K. Barton	72	1989	Independent Director
Mark C. Genovese	-	-	Member of Scientific Advisory Board

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

I Agree

Gilead (GILD) Price Discussion

Write your thoughts about Gilead Sciences Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Oc Masai Apr 27, 2021 7:54

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Good job GILD. bullish move forward

0 0

Report

Ashraf Elgendy Mar 07, 2021 13:03

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...

2 1

Report

RM RM Mar 01, 2021 21:53

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Up Again

1 0

Report

Ken Laing Oct 23, 2020 18:43

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Time to load up before the big rise coming next week

3 3

Report

Iggy Maldon Jul 30, 2020 20:22

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Classic pump n’ dump. What a shambles

5 1

Report

RM RM May 28, 2020 22:24

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Will reach above 95

10 5

Report

Chili Daug May 28, 2020 22:24

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

when? hahah

0 0

Report

SAGAR AGARWAL May 15, 2020 14:52

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Good time to accumulate.

4 1

Report

Khizer Malik May 14, 2020 11:04

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr

8 2

Report

Willy Chin Apr 23, 2020 18:14

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

High chance to be trading above 90, good long stock

9 4

Report

Viktor Veselý Apr 12, 2020 7:48

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.

4 3

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="204313794">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="204313794" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="204313794" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="204313794">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="200889478">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="200889478" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="200889478" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="200889478">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

FTSE 100	8,990.49	+17.85	+0.20%
DAX	24,431.77	+64.30	+0.26%
Euro Stoxx 50	5,394.85	+17.70	+0.33%
S&P 500	6,297.36	+33.66	+0.54%
Nikkei 225	39,834.00	-67.19	-0.17%
Dow Jones	44,484.49	+229.71	+0.52%
FTSE 100 Futures	8,989.8	+4.2	+0.05%

Brent Oil	70.15	+0.63	+0.91%
Crude Oil WTI	68.28	+0.74	+1.10%
Gold	3,357.60	+12.30	+0.37%
Silver	38.710	+0.407	+1.06%
Copper	5.5832	+0.0707	+1.28%
London Cocoa	4,803.00	-382.00	-7.37%
London Wheat	178.25	+1.05	+0.59%

U.K. 10Y	4.6770	+0.0160	+0.34%
U.K. 5Y	4.1000	+0.0080	+0.20%
U.K. 2Y	3.9180	+0.0070	+0.18%
Germany 10Y	2.6940	+0.0190	+0.71%
U.S. 10Y	4.442	-0.022	-0.49%
U.S. 5Y	3.980	-0.026	-0.65%
U.S. 2Y	3.894	-0.023	-0.59%

Lloyds Banking	77.64	-0.56	-0.72%
Vodafone Group PLC	82.060	+0.060	+0.07%
Barclays	348.05	-3.15	-0.90%
BT Group	197.75	-0.10	-0.05%
HSBC	931.60	-1.10	-0.12%
BHP Group Ltd	1,939.50	+25.50	+1.33%
Exxon Mobil	111.66	-0.57	-0.51%

Recent Quotes

	Name	Price	Chg.	Chg. %
	GILD	94.070	0.000	0.00%

Market Movers

Name	Last	Chg. %	Vol.
GSK plc	1,331.50	-5.77%	7.31M
HSBC	931.40	-0.14%	6.31M
Rolls-Royce Holdings	1,006.35	-0.36%	3.65M
Shell	2,642.2	+1.27%	1.30M
Rio Tinto PLC	4,519.0	+2.01%	767.83K
British American Tobacco	3,797.0	-0.42%	680.76K
AstraZeneca	10,278.0	-0.33%	373.88K

Name	Last	Chg. %	Vol.
Atos	28.0000	+777677.78%	1.16K
Fincantieri	16.39	+3051.92%	23.95K
Ensurge Micropower ASA	1.262	+480.46%	6.70K
Inteliqo	0.03	+400.99%	0
Heijmans	56.10	+228.45%	1.29K
MFE MEDIAFOREUROPE NV B	3.832	+216.96%	1.21K
Spotify Tech	619.2000	+149.68%	3.00

Name	Last	Chg. %	Vol.
Wirecard	0.0178	-97.40%	196.00
Mynaric	1.10	-94.66%	0
Wolfspeed	1.44	-94.63%	6.40K
Tamar Minerals	0.002	-94.29%	0
Rapid Nutrition	0.0070	-90.00%	490.85K
Aena	23.48	-89.90%	2.82K
Rockwool B	293.60	-88.76%	136.00

Webinars

From Beginner to Pro: Navigating Your InvestingPro Subscription Wednesday, July 30, 2025 | 15:00 BST